[1]
Solano Peña, G.A., Acurio Armas, G.F., Díaz Teran, G.A., Palacios Serrano, S.P., Cobo Reyes, A.C., Pullas Taboada, D.A. and Carvajal Chango, G.K. 2023. PCSK9 inhibition: a new alternative to reduce cholesterol and prevent atherosclerotic cardiovascular disease. Salud, Ciencia y Tecnología. 3, (Nov. 2023), 587. DOI:https://doi.org/10.56294/saludcyt2023587.